STAT+: Health plan formularies lowered barriers to fair access to some drugs, analysis finds
STAT
DECEMBER 19, 2024
Department of Veterans Affairs. Although there is a caveat: This particular metric was based on a subset of just three drugs that were deemed to be fairly priced based on a cost-effectiveness assessment — the Mounjaro type 2 diabetes treatment, and the Wegovy and Qsymia obesity drugs.
Let's personalize your content